From Medscape Oncology

American Society for Radiation Oncology (ASTRO) 2023 Annual Meeting

October 01 - 04, 2023; San Diego, California and Virtual/Online

October 01 - 04, 2023 San Diego, California and Virtual/Online

ASTRO 2023 Short-Course SBRT: Standard of Care in Prostate Cancer? For patients with low and favorable intermediate-risk prostate cancer, stereotactic body radiation therapy delivered in five fractions provided similar 5-year disease control as conventional, higher-dose external-beam radiation.
Medscape Medical News, October 4, 2023
ASTRO 2023 Salvage Option to Replace Transplant in RR Hodgkin Lymphoma? A chemoimmunotherapy and radiation combination without autologous stem cell transplant produced high response rates in children and young adults with low-risk relapsed/refractory Hodgkin lymphoma.
Medscape Medical News, October 3, 2023

Medscape Oncology©

Perspectives

Popular News from Last Year’s ASTRO Annual Meeting

'Groundbreaking': Prophylactic Radiotherapy Ups Survival Prophylactic radiotherapy for asymptomatic bone metastases could become standard of care after a randomized trial showed that it improved overall survival as well as reducing skeletal-related events.
Medscape Medical News, Oct 26, 2022
Bone Metastases Treated in a FLASH: One Dose of Proton RT The first-in-human trial of FLASH ultra-high-dose-rate proton radiotherapy shows that it offers pain relief with few toxicities to cancer patients with bone metastases.
Medscape Medical News, Oct 25, 2022
When a Cyberattack Halts Radiation Therapy: Not 'If' but 'When' Three radiation oncologists describe living through cyberattacks that paralyzed their clinics. They urge all clinicians to make plans to keep services running so that patients don't miss out on treatment.
Medscape Medical News, Nov 10, 2022

Previous Coverage